Stem cell conference at U of T to focus on entrepreneurship. U of T News, July 11, 2017.
Spotlight: Ontario's Regenerative Medicine Pipeline. Biotechnology Focus, June 30, 2017.
Tissue engineering pioneer Michael Sefton to lead Medicine by Design as Executive Director. University of Toronto Faculty of Medicine News, June 28, 2017.
CRISPR: Emerging applications for genome editing technology. Technology Networks, June 26, 2017.
Forging Partnerships In Regenerative Medicine Helps Make Canada A World Leader. National Post - Media Planet, June 22, 2017.
The big guys are here to stay. Biotechnology Focus, June 20, 2017.
What is BlueRock working on? Biotechnology Focus, June 15, 2017.
Top 10 Stem Cell Companies on the NASDAQ. INN Daily, June 14, 2017.
U of T research helps pave the way for an off-the-shelf supply of cells for immunotherapy. Medicine by Design, University of Toronto website, May 25, 2017.
OIRM 2016 Annual Report. OIRM website, May 25, 2017.
BlueRock: Canada's stem cell contender on the journey from petri dish to clinical trial. Pharmaceutical-technology.com, May 22, 2017.
Streamlining Stem Cell Manufacturing. GEN, April 24, 2017.
$225M BlueRock Therapeutics "monster" a magnet for Canada's biotech sector. Financial Post, April 10, 2017.
Ontario's home-grown stem cell contender. Pharmacy Choice, March 21, 2017.
Canada shoots for tech boost as Trump shuts doors. The Times of Israel, March 12, 2017.
BrainStorm seeks early Health Canada nod for NurOwn treatment. Drug Delivery Business News, February 22, 2017.
Observers urge care in earmarking funds for innovation clusters. The Hill Times, February 8, 2017.
Collaboration brings together MBA and PhD students to map regenerative medicine ecosystem. Medicine by Design, University of Toronto website. February 2, 2017.
Une exposition sur les cellules souches au Musee du Fjord. Le Courrier de Saguenay, January 15, 2017.